Terms: = Germ cell tumor AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
18 results:
1. Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.
Scholl JN; Weber AF; Dias CK; Lima VP; Grun LK; Zambonin D; Anzolin E; Dos Santos Dias WW; Kus WP; Barbé-Tuana F; Battastini AMO; Worm PV; Figueiró F
Purinergic Signal; 2024 Feb; 20(1):47-64. PubMed ID: 36964277
[TBL] [Abstract] [Full Text] [Related]
2. Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma.
Cai J; Hu Y; Ye Z; Ye L; Gao L; Wang Y; Sun Q; Tong S; Yang J; Chen Q
Front Immunol; 2022; 13():1011757. PubMed ID: 36325335
[TBL] [Abstract] [Full Text] [Related]
3. Immune contexture of paediatric cancers.
Thakur MD; Franz CJ; Brennan L; Brouwer-Visser J; Tam R; Korski K; Koeppen H; Ziai J; Babitzki G; Ranchere-Vince D; Vasiljevic A; Dijoud F; Marec-Bérard P; Rochet I; Cannarile MA; Marabelle A
Eur J Cancer; 2022 Jul; 170():179-193. PubMed ID: 35660252
[TBL] [Abstract] [Full Text] [Related]
4. Survival Outcomes of Patients with Clinical Stage III Melanoma in the Era of Novel Systemic Therapies.
Song Y; Tieniber AD; Gimotty PA; Mitchell TC; Amaravadi RK; Schuchter LM; Fraker DL; Karakousis GC
Ann Surg Oncol; 2019 Dec; 26(13):4621-4630. PubMed ID: 31270717
[TBL] [Abstract] [Full Text] [Related]
5. EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Li Z; Takenobu H; Setyawati AN; Akita N; Haruta M; Satoh S; Shinno Y; Chikaraishi K; Mukae K; Akter J; Sugino RP; Nakazawa A; Nakagawara A; Aburatani H; Ohira M; Kamijo T
Oncogene; 2018 May; 37(20):2714-2727. PubMed ID: 29507419
[TBL] [Abstract] [Full Text] [Related]
6. Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio-chemotherapy.
Pasqualetti F; Gonnelli A; Cantarella M; Delishaj D; Molinari A; Ortenzi V; Carbone F; Montrone S; Ursino S; Franceschi S; Morganti R; Orlandi P; Di Desidero T; Mazzanti CM; Zavaglia K; Naccarato AG; Bocci G; Paiar F
Invest New Drugs; 2018 Apr; 36(2):340-345. PubMed ID: 28965273
[TBL] [Abstract] [Full Text] [Related]
7. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma.
Cui R; Guan Y; Sun C; Chen L; Bao Y; Li G; Qiu B; Meng X; Pang C; Wang Y
Cancer Lett; 2016 Apr; 374(1):1-11. PubMed ID: 26854715
[TBL] [Abstract] [Full Text] [Related]
8. Expression of FOXP3, CD14, and ARG1 in Neuroblastoma tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival.
Stigliani S; Croce M; Morandi F; Scaruffi P; Rigo V; Carlini B; Manzitti C; Gigliotti AR; Tonini GP; Pistoia V; Ferrini S; Corrias MV
Biomed Res Int; 2015; 2015():347867. PubMed ID: 26161395
[TBL] [Abstract] [Full Text] [Related]
9. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
[TBL] [Abstract] [Full Text] [Related]
10. The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.
Tentori L; Dorio AS; Mazzon E; Muzi A; Sau A; Cuzzocrea S; Vernole P; Federici G; Caccuri AM; Graziani G
Eur J Cancer; 2011 May; 47(8):1219-30. PubMed ID: 21269821
[TBL] [Abstract] [Full Text] [Related]
11. Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients.
Gadji M; Fortin D; Tsanaclis AM; Garini Y; Katzir N; Wienburg Y; Yan J; Klewes L; Klonisch T; Drouin R; Mai S
Neoplasia; 2010 Feb; 12(2):183-91. PubMed ID: 20126476
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of increase in transcript levels of Tp73 DeltaEx2-3 isoforms in low-grade glioma patients.
Wager M; Guilhot J; Blanc JL; Ferrand S; Milin S; Bataille B; Lapierre F; Denis S; Chantereau T; Larsen CJ; Karayan-Tapon L
Br J Cancer; 2006 Oct; 95(8):1062-9. PubMed ID: 17047653
[TBL] [Abstract] [Full Text] [Related]
13. Molecular classification of human gliomas using matrix-based comparative genomic hybridization.
Roerig P; Nessling M; Radlwimmer B; Joos S; Wrobel G; Schwaenen C; Reifenberger G; Lichter P
Int J Cancer; 2005 Oct; 117(1):95-103. PubMed ID: 15880582
[TBL] [Abstract] [Full Text] [Related]
14. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.
Frost MJ; Ferrao PT; Hughes TP; Ashman LK
Mol Cancer Ther; 2002 Oct; 1(12):1115-24. PubMed ID: 12481435
[TBL] [Abstract] [Full Text] [Related]
15. Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression.
Miyake K; Kimura S; Nakanishi M; Hisada A; Hasegawa M; Nagao S; Abe Y
J Neuropathol Exp Neurol; 2000 Jan; 59(1):18-28. PubMed ID: 10744032
[TBL] [Abstract] [Full Text] [Related]
16. Increased laminin-1 expression in hydatidiform mole.
Iwahashi M; Muragaki Y; Ooshima A; Nakano R
Mol Hum Reprod; 1997 Dec; 3(12):1107-11. PubMed ID: 9464856
[TBL] [Abstract] [Full Text] [Related]
17. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
[TBL] [Abstract] [Full Text] [Related]
18. The prevalence and prognostic significance of trophoblastic proteins in testicular teratoma.
Masters JR; Parkinson MC; Miller ID; Horne CH
Diagn Histopathol; 1983; 6(3-4):247-52. PubMed ID: 6676077
[TBL] [Abstract] [Full Text] [Related]
